當前位置：上海經(jīng)科化學科技有限公司>>抗體>>流式抗體>>Anti-Human CD279 （PD-1） PE-Cy7

Anti-Human CD279 （PD-1） PE-Cy7

返回列表頁

參考價

面議

具體成交價以合同協(xié)議為準

產(chǎn)品型號25 tests

品牌

廠商性質(zhì)經(jīng)銷商

所在地上海市

在線詢價收藏產(chǎn)品查看聯(lián)系電話

聯(lián)系方式：李小姐查看聯(lián)系方式

更新時間：2017-08-09 19:46:36瀏覽次數(shù)：827次

聯(lián)系我時，請告知來自環(huán)保在線

產(chǎn)品分類 品牌分類

  抗體

流式抗體

全部產(chǎn)品列表

暫無信息

上海經(jīng)科化學科技有限公司

經(jīng)營模式：經(jīng)銷商

商鋪產(chǎn)品：183條

所在地區(qū)：上海上海市

聯(lián)系人：李小姐

詢價 給他留言

產(chǎn)品簡介

Anti-Human CD279 (PD-1) PE-Cy7
Clone: eBioJ105 (J105)
RUO: For Research Use Only. Not for use in diagnostic procedures.

詳細介紹

Description: The J105 monoclonal antibody reacts with the human PD-1 （programmed death-1）, a 55 kDa member of the CD28 immunoglobulin superfamily. PD-1 contains the immunoreceptor tyrosine-based inhibitory motif （ITIM） and plays a key role in peripheral tolerance and autoimmune disease. PD-1 is expressed predominantly on activated T and B lymphocytes. Two novel members of the B7 family have been identified as the PD-1 ligands, PD-L1 （B7-H1） and PD-L2 （B7-DC）. Evidence reported to date suggests overlapping functions for these two PD-1 ligands and their constitutive expression on some normal tissues and upregulation on activated antigen-presenting cells.
Costaining experiments suggest that eBioJ105 recognizes a different epitope than MIH4 （cat. 11-9969）.